To access this element change to forms mode OFF
Grant Award View - GA201624
Understanding the control of cell death and the functions of the tumour...
GA ID:
GA201624
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$4,319,716.50
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Understanding the control of cell death and the functions of the tumour suppressor p53 to develop improved therapies for cancer
Purpose:
Cancer is a leading cause of morbidity and mortality in Australia and worldwide, imposing a substantial burden on affected families and the health care system. I will build on my previous success of delivering a highly successful new anti-cancer drug (venetoclax) to market by determining the mechanisms that control the killing of cancer cells and the suppression of tumour development. My aim is to kick-start translational programs to develop new anti-cancer drugs.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2007887
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA